Truscreen Group Ltd

Chart & Performance

D1W1MN

P/E

—

P/S

8.29

EPS

—

Div Yield, %

—

Shrs. gr., 5y

18.84%

Rev. gr., 5y

5.85%

Revenues

-34.21%

Net income

-2m

L+9.41%

CFO

-2m

L+12.60%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Truscreen Group Limited, together with its subsidiaries, develops, manufactures, and sells cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening system, a medical device for detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.

URL

https://truscreen.com/

IPO date

Nov 12, 2014

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title NZD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title NZD in thousands, except ratios and share amounts	2025‑03	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT